CVE-2015-1012

mediumpriority · track · 30OT risk · elevatedEPSS 0.008 · 55 %ileEUUS
grimoire priorityP3 · Track
Exploitable?
—
no known exploitation
Likely / severe?
0.77% (55th) EPSS
CVSS 5 · medium
Is it mine?
4 products
Check your exposure
Who says so?
4 sources
cnnvd · enisa_euvd · cisa_csaf_ot · nvd

EPSS · scored 2026-10-23

Wireless keys are stored in plain text on version 5 of the Hospira LifeCare PCA Infusion System. According to Hospira, version 3 of the LifeCare PCA Infusion System is not indicated for wireless use, is not shipped with wireless capabilities, and should not be modified to be used in a wireless capacity in a clinical setting. Hospira has developed a new version of the PCS Infusion System, version 7.0 that addresses the identified vulnerabilities. Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.

01

remediations

Vendor fix, mitigation, or workaround guidance, as published by each source.

No vendor fix yet; a mitigation is available.

  • MitigationLifeCare PCA Infusion Systemcisa_csaf_ot

    Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.

  • MitigationLifeCare PCA Infusion Systemcisa_csaf_ot

    CS-CERT has been working with Hospira since May 2014 to address the vulnerabilities in the LifeCare PCA Infusion System. Hospira has developed a new version of the PCS Infusion System, Version 7.0 that addresses the identified vulnerabilities. According to Hospira, Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access. Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira’s Version 7.0 is being reviewed by the FDA prior to its release. The release date for Version 7.0 of the LifeCare PCA Infusion System has not been determined. For additional information about Hospira’s new release, contact Hospira’s technical support at 1‑800-241-4002. ICS-CERT encourages asset owners to take defensive measures to protect against this and other cybersecurity risks.

02

cvss

Technical severity, 0–10. One row per scoring source.

7.5
010

base score 0–10 · higher = more severe · hover a vector to decode⚠ sources disagree · medium–high · 5–7.5

v2.05mediumAV:N/AC:L/Au:N/C:P/I:N/A:Nprimary · NVD / NIST USexploitability 10 · impact 2.9
v3.07.5highCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:Nprimary · NVD / NIST USexploitability 3.9 · impact 3.6
v2.06.4mediumAV:N/AC:L/Au:N/C:P/I:P/A:Nsecondary · CISA US
v3.06.9mediumCVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N/E:Usecondary · CVSS-BT (t0sche)
03

weaknesses

The CWE weakness classes this flaw belongs to.

04

affected products (4)

Products and version ranges known to be affected.

05

advisories (2)

Vendor and ecosystem advisories describing this.

  • ICSA-15-125-01BHospira LifeCare PCA Infusion System Vulnerabilities2015-02-05icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

  • ICSA-15-132-01Hospira LifeCare PCA Infusion System Vulnerabilities2015-02-12icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

06

also known as (3)

Other names and identifiers for this entity.

07

sources

Which sources assert this record, and when.

published 2019-03-25modified 2026-06-17
09

references (5)

External citations — patches, advisories, analysis.

scry

Attackers weaponise vulnerabilities like this against internet-exposed services. See what is exposed on your perimeter with a free passive scan.

Free scan